State Street Corporation 13D and 13G filings for Travere Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-18 11:59 am Sale | 2024-09-30 | 13G | Travere Therapeutics, Inc. TVTX | STATE STREET CORP STT | 2,736,696 3.600% | -2,615,649 (-48.87%) | Filing |
| 2024-01-25 09:24 am Purchase | 2023-12-31 | 13G | Travere Therapeutics, Inc. TVTX | STATE STREET CORP STT | 5,352,345 7.120% | 1,128,321 (+26.71%) | Filing |
| 2023-02-06 2:55 pm Purchase | 2022-12-31 | 13G | Travere Therapeutics, Inc. TVTX | STATE STREET CORP STT | 4,224,024 6.580% | 4,224,024 (New Position) | Filing |